(Q39131426)

English

Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line

scientific article published on 2 July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

ChEBI release 2020-05-28

neoplastic stem cells

1 reference

based on heuristic

inferred from title

cancer cell line

1 reference

based on heuristic

inferred from title

Zdeněk Hostomský

14

object named as

Zdenek Hostomsky

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Douglas D Fang

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Joan Cao

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jitesh P Jani

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Konstantinos Tsaparikos

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Alessandra Blasina

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jill Kornmann

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Maruja E Lira

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jianying Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Zuzana Jirout

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Justin Bingham

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Zhou Zhu

11

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yin Gu

12

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Gerrit Los

13

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Todd Vanarsdale

15

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

2 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Frontiers of medicine

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

462-476

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Identification of selective inhibitors of cancer stem cells by high-throughput screening

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

A tumorigenic subpopulation with stem cell properties in melanomas

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Radial glia cells are candidate stem cells of ependymoma

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Identification and expansion of human colon-cancer-initiating cells

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Identification and expansion of the tumorigenic lung cancer stem cell population

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Isolation of a novel population of multipotent adult stem cells from human hair follicles

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Phase II trial of neoadjuvant therapy with carboplatin, gemcitabine plus thalidomide for stages IIB and III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest

1 reference

https://api.crossref.org/works/10.1007%2FS11684-013-0270-6

21 January 2018

Identification of a cancer stem cell in human brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23820871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models

1 reference

https://pubmed.ncbi.nlm.nih.gov/23820871

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11684-013-0270-6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39131426&oldid=2202586038"